Kyle Silva, DO
Pain Medicine · Winchester, MANPI 1427396019
Payments from drug & device makers
What this record shows
6 manufacturers reported payments, led by Boston Scientific at 46.2% of the total.
Across 35 payments — averaging $131.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Pacira Pharmaceuticals Incorporated$1K
- Stryker$1K
- SPR Therapeutics, Inc$255
- Johnson & Johnson$123
- Nevro Corp.$19
What the payments were for
- Travel & lodging$2,75360%
- Food & beverage$1,83740%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 13 | $2,118 |
| Pacira Pharmaceuticals Incorporated | 4 | $1,057 |
| Stryker | 8 | $1,019 |
| SPR Therapeutics, Inc | 3 | $255 |
| Johnson & Johnson | 6 | $123 |
| Nevro Corp. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Iovera$1,004
- mild Device Kit$771
- Intracept$296
- GENERAL PAIN MANAGEMENT$137
- SPRINT PNS System$137
- Zilretta$125
How this compares
$4,590 in reported general payments places this provider in the 70th percentile of 137 pain medicine providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine | 32 | $2,280 |
| Gabapentin | 124 | $1,417 |
| Pregabalin | 49 | $805 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 21 | $252 |
| Cyclobenzaprine Hcl | 22 | $164 |
| Duloxetine Hcl | 27 | $155 |
| Celecoxib | 11 | $120 |
| Meloxicam | 20 | $74 |
| Tramadol Hcl | 13 | $66 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 13 | $63 |
| Diazepam | 13 | $27 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Winchester
- Hariharan SundramNewton$1.7M
- Thomas SimopoulosBoston$181K
- Ivan UritsWareham$70K
- Antje BarreveldNewton$64K
- Arti OriBoston$62K
- Christine SangBoston$56K
- Ali EbrahimiBurlington$41K
- Alexandra AdlerLowell$35K
- Eduard VaynbergBoston$32K
- David GarasNatick$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.